Biocatalysis | Chemical Biology of the Cell | Control of Gene Expression | Liver Biology & Pathobiology
Methionine regeneration by homocysteine remethylation in healthy and tumoral liver tissues
Hélène Pellanda, Bernard Namour, Ma'atem Fofou-Caillierez, Aude Bressenot, Jean-Marc Alberto, Céline Chéry, Ahmet Ayav, Jean-Pierre Bronowicki, Jean-Louis Guéant*, Thierry Forges
*Corresponding author: Jean-Louis Guéant
Faculty of Medicine, Nutrition-génétique et exposition aux risques environnementaux (NGERE), Vandoeuvre-lès-Nancy, France
F1000Posters 2012, 3: 179 (poster) [English]
Poster [640.41 KB] | Recommended by F1000Prime | Resulting articles
Presented at
Advances and Controversies in B-Vitamins and Choline Conference 2012,
4 - 7 Mar 2012, P5 03
The remethylation of homocysteine into methionine is catalyzed by either methionine synthase (MTR) or by betaine-homocysteine methyltransferase (BHMT) in the liver. Choline/betaine deficiency and an impaired BHMT pathway have been associated with hepatocellular carcinogenesis in animal models. The molecular mechanisms that impair the BHMT pathway are unknown. We aimed to investigate BHMT, BHMT2, and MTR expression in both HepG2 cells and human hepatocarcinoma tissues.
A transcription variant of exon 4 produces a loss of function of BHMT in human hepatocarcinoma. This opens new insights for targeting MTR in chemotherapy of hepatocarcinoma. Whether this abnormal transcription of BHMT is part or consequence of liver carcinogenesis warrants further investigation.
No relevant competing interests disclosed.
Please note that most posters on this site present work that is preliminary in nature and has not been peer reviewed.
This poster is open access subject to the CC BY-NC Creative Commons 3.0 License
